Corient Capital Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $1.11M | Buy |
6,625
+462
| +7% | +$77.6K | 0.08% | 202 |
|
2022
Q2 | $1.04M | Sell |
6,163
-993
| -14% | -$167K | 0.08% | 220 |
|
2022
Q1 | $1.79M | Buy |
7,156
+1,009
| +16% | +$253K | 0.12% | 157 |
|
2021
Q4 | $1.58M | Buy |
6,147
+28
| +0.5% | +$7.2K | 0.1% | 173 |
|
2021
Q3 | $1.49M | Sell |
6,119
-391
| -6% | -$94.9K | 0.11% | 174 |
|
2021
Q2 | $1.35M | Buy |
6,510
+311
| +5% | +$64.3K | 0.1% | 184 |
|
2021
Q1 | $1.17M | Buy |
6,199
+398
| +7% | +$74.9K | 0.1% | 183 |
|
2020
Q4 | $954K | Buy |
5,801
+204
| +4% | +$33.5K | 0.1% | 186 |
|
2020
Q3 | $698K | Buy |
5,597
+96
| +2% | +$12K | 0.08% | 211 |
|
2020
Q2 | $534K | Buy |
5,501
+29
| +0.5% | +$2.82K | 0.07% | 239 |
|
2020
Q1 | $492K | Sell |
5,472
-7,440
| -58% | -$669K | 0.08% | 218 |
|
2019
Q4 | $1.91M | Sell |
12,912
-1,113
| -8% | -$165K | 0.24% | 92 |
|
2019
Q3 | $1.69M | Sell |
14,025
-2,492
| -15% | -$300K | 0.24% | 96 |
|
2019
Q2 | $2.23M | Sell |
16,517
-887
| -5% | -$120K | 0.34% | 66 |
|
2019
Q1 | $2.27M | Sell |
17,404
-3,606
| -17% | -$470K | 0.37% | 66 |
|
2018
Q4 | $2.62M | Sell |
21,010
-9,128
| -30% | -$1.14M | 0.47% | 43 |
|
2018
Q3 | $4.19M | Hold |
30,138
| – | – | 0.7% | 25 |
|
2018
Q2 | $3.09M | Sell |
30,138
-156
| -0.5% | -$16K | 0.54% | 40 |
|
2018
Q1 | $2.94M | Sell |
30,294
-2,478
| -8% | -$240K | 0.54% | 42 |
|
2017
Q4 | $2.88M | Buy |
32,772
+1,967
| +6% | +$173K | 0.49% | 61 |
|
2017
Q3 | $2.45M | Sell |
30,805
-184
| -0.6% | -$14.6K | 0.46% | 60 |
|
2017
Q2 | $2.7M | Sell |
30,989
-1,439
| -4% | -$125K | 0.41% | 64 |
|
2017
Q1 | $2.89M | Buy |
32,428
+887
| +3% | +$78.9K | 0.45% | 51 |
|
2016
Q4 | $2.34M | Buy |
31,541
+8,456
| +37% | +$626K | 0.41% | 62 |
|
2016
Q3 | $1.75M | Buy |
+23,085
| New | +$1.75M | 0.32% | 84 |
|